1. Iversen P et al. Scan J Urol Nephrol Suppl 1995; 172: 65-72 2. Graversen PH et al. Urolgy 1990; 36: 493-498 3. Johansson JE at al. JAMA 1997; 277:467-71 4. Lu-Yao GL et al. Lancet 1997; 349:907 5. Waaler G et al. British Journal of Urology 1993; 72:214-19 6. Choda GW et al. New Engl J Med 1994; 330:242-48 7. Wasson JH et al. Archives of Family Medicine 1993; 2:487-93 8. Holmberg L et al. N Engl J Med 2002; 347:781-789 9. See WA et al. J Urol 2002 Aug; 168 (2): 429-35. 10. Bayar DP et al. NCI Monograph 1988, 7: 165-170 11. The Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urol 1997; 79: 235-246 12. Fellow GJ et al.Br J Urol 1992; 70:304-309 13. Messing EM et al. N Engl J Med 1999; 341: 1781-1789 14. Robson M et al. Haematol Oncol Clin North Am 1996; 10: 727-747 15. Prostate Cancer Clinical Trialists’ Collaborative Group. Lancet 2000; 355: 1491-1498 16. Caubert JF et al. Urology 1997; 49: 71-78 17. Bennet CI et al.Prostate Cancer Prostat Dis 1999; 24-28 18. Schmitt B.et al. Cochrane Review. In: The Cochrane Library, Issue 1 2003. Oxford: Update Software 19. Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urol 1997; 79: 235 20. Wilt T et al. Cochrane Review. In: The Cochrane Library, Issue 1 2003. Oxford: Update Software 21. Seidenfeld et al. Ann Int Med. 2000; 132: 566 – 577 22. Pound CR et al. JAMA 1999; 281:159-67 23. Linee Guida del National Comprehensive Cancer Network (Oncology, Vol 13, No 11 A , Nov. 1999). Sito internet: "http://www.cancernetwork.com/journals/Oncology/NCCN991108.HTM" 24. Sharifi N et al. Androgen Deprivation Therapy for Prostate Cancer. JAMA 2005 Jul 13; 294:238-244. 25. Bolla M et al for the European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTIC trial 22911). Lancet 2005 Aug 13; 366:572-578 26. Keating LN et al. Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer. Journal of Clinical Oncology, Vol 24, No 27 (September 20), 2006: pp. 4448-4456. 28. Thompson IM et al. Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer.A Randomized Clinical Trial . JAMA. 2006 Nov 15;296:2329-2335 29. G Boustead et al. Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials. BJU International 2007 Epub March 6 (doi:10.1111/j.1464-410X.2007.06802.x) 30. Wong Yu-Ning et al. Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men. JAMA. 2006 Dec 13;296:2683-2693. 31. Thompson I et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007;177:2106-31. http://www.auanet.org/guidelines/main_reports/proscan07/content.pdf (accesso del 28 dicembre 2007) 32. Trock BJ et al. Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy. JAMA. 2008 Jun 18;299:2760-2769. 33. Thompson IA et al. Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial.J Urol 2009;181:956-962.
|
|
